Select Page

The Food and Drug Administration (FDA) has released an update to the labeling rule regarding products for pregnancy and lactation.  John C Jennings, MD, President of the American College of Obstetricians and Gynecologists (ACOG), released the update and addressed the Food and Drug Administration:

“The American College of Obstetricians and Gynecologists applauds the Food and Drug Administration (FDA) for taking needed steps to increase understanding about the effect of prescription medicines on women during pregnancy and lactation…”

The new update requires there to be information on medication about risks and benefits to women who are pregnant or lactating.  This is an extremely necessary update and will be beneficial to all physicians treating pregnant, breastfeeding, and potentially pregnant women.  With the label on the bottle, it will also encourage women to be more aware of what they are putting in their bodies, which is a healthy habit for anyone to have, especially pregnant women.

Medications can be vital to maintaining a mother’s health during pregnancies.  They are meant to help the mother and unborn child, not harm them.  ACOG also hopes that inclusion of more information on prescription medicines will give more incentive for participation in patient registries.  They would like to get a better idea of the impact that prescription medicines have on pregnant and breastfeeding women.  More research can only aid the healthcare industry and help to improve healthcare for women in the future.

This new rule by the FDA will be implemented in June of 2015.  Prior to that, ACOG will review the rule and come up with any necessary educational resources for physicians and patients.  This is a great addition. Good job, FDA!

More information on the new rule can be found here.